Pharma

All news and posts of our editorial team on the topic

Pharmaceutical package: Commission promises better drug supply
The Commission wants to give EU citizens better access to medicines with its pharmaceutical package. However, the Commission's proposal is also tailored to the pharmaceutical industry. New drugs may remain protected for up to 13 years. continue reading →
Pharma: Pressure grows continuously
The expectations that companies deal with sustainability risks are increasing. The pressure is also growing in the pharmaceutical industry. At first glance, the highly regulated industry does not need to worry too much in the so-called ESG area. However, controversies are looming, especially when it comes to social criteria. continue reading →
Escape to the future: Pharmaceutical industry wants to improve access to medicines
The EU Commission intends to revise European pharmaceutical legislation at the end of 2022. Even during the consultations at the end of 2021, the pharmaceutical industry did not see any fundamental need for improvement. However, now, it is taking the plunge and presenting its own proposals to make access to medicines faster and fairer for millions of patients in the EU. continue reading →
Max Müller – Bayer’s chief lobbyist
Never talk to a pharmacist about Max Müller, and if you do, hope you can run faster. For years, Max Müller, the face of the online pharmacy DocMorris, received the concentrated fury of the German pharmacy community. The anger about an upheaval, about a conflict between the established pharmacies and the new online start-ups. For […] continue reading →
Russia sanctions also affect healthcare industry
The export of medical or pharmaceutical goods is largely exempt from EU sanctions. Nevertheless, manufacturers are directly or indirectly affected. The consequences of the conflict could also be far-reaching for clinical trials. continue reading →